קסופלוזה 20 מג ישראל - עברית - Ministry of Health

קסופלוזה 20 מג

roche pharmaceuticals (israel) ltd - baloxavir marboxil - טבליות מצופות פילם - baloxavir marboxil 20 mg - baloxavir marboxil

קסופלוזה 40 מג ישראל - עברית - Ministry of Health

קסופלוזה 40 מג

roche pharmaceuticals (israel) ltd - baloxavir marboxil - טבליות מצופות פילם - baloxavir marboxil 40 mg - baloxavir marboxil

פרזיסטה 75 מג ישראל - עברית - Ministry of Health

פרזיסטה 75 מג

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 75 mg - darunavir - darunavir - adult patients : prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv -1) infection. this indication is based on analyses of plasma hiv rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment - naive and treatment -experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment -experienced adult patients .pediatric patients :prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of hiv in pediatric patients 6 years of age and older. this indication is based on week 24 analyses of plasma hiv rna levels and cd4+ cell counts from an open-label phase 2 trial in antiretroviral treatment -experienced pediatric patients 6 to < 18 years of age. in treatment-experienced adult and pediatric the following points should be considered when ini

פרזיסטה 150 מג ישראל - עברית - Ministry of Health

פרזיסטה 150 מג

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 150 mg - darunavir - darunavir - adult patients : prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv -1) infection. this indication is based on analyses of plasma hiv rna levels and cd4+ cell counts from 2 controlled phase 3 trials of 48 weeks duration in antiretroviral treatment - naive and treatment -experienced patients and 2 controlled phase 2 trials of 96 weeks duration in clinically advanced, treatment -experienced adult patients .pediatric patients :prezista, co-administered with ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of hiv in pediatric patients 6 years of age and older. this indication is based on week 24 analyses of plasma hiv rna levels and cd4+ cell counts from an open-label phase 2 trial in antiretroviral treatment -experienced pediatric patients 6 to < 18 years of age. in treatment-experienced adult and pediatric the following points should be considered when ini

פרזיסטה 400 מג ישראל - עברית - Ministry of Health

פרזיסטה 400 מג

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 400 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

פרזיסטה 600 מג ישראל - עברית - Ministry of Health

פרזיסטה 600 מג

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 600 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

נורויר 100 מג טבליות ישראל - עברית - Ministry of Health

נורויר 100 מג טבליות

abbvie biopharmaceuticals ltd, israel - ritonavir - טבליות מצופות פילם - ritonavir 100 mg - ritonavir - ritonavir - is indicated alone or in combination with other antiretroviral agents for the treatment of patients with hiv infection when therapy is warranted based on clinical and/or immunological evidence of disease progression

דרונאביר טבע   800 מג ישראל - עברית - Ministry of Health

דרונאביר טבע 800 מג

teva pharmaceutical industries ltd, israel - darunavir - טבליות מצופות פילם - darunavir 800 mg - darunavir

דרונאביר טבע 600 מג     ישראל - עברית - Ministry of Health

דרונאביר טבע 600 מג

teva pharmaceutical industries ltd, israel - darunavir - טבליות מצופות פילם - darunavir 600 mg - darunavir

קלטרה תמיסה לשתייה ישראל - עברית - Ministry of Health

קלטרה תמיסה לשתייה

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - תמיסה (פומי) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.